
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year in the United States, a new study claims. Obesity and all its attendant ills — type 2 diabetes, heart disease and cancer among them — have had a dramatic impact on American health, researchers said.… read on > read on >